Download presentation
Presentation is loading. Please wait.
Published byHadi Sanjaya Modified over 5 years ago
1
Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma
Arianna Barbetta, MD, Francisco Schlottmann, MD, Tamar Nobel, MD, David B. Sewell, MA, Meier Hsu, MS, Kay See Tan, PhD, Hans Gerdes, MD, Pari Shah, MD, Manjit S. Bains, MD, Matthew Bott, MD, James M. Isbell, MD, David R. Jones, MD, Daniela Molena, MD The Annals of Thoracic Surgery Volume 106, Issue 1, Pages (July 2018) DOI: /j.athoracsur Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Three-year and 5-year overall survival for patients with (N+) and without (N−) nodal disease. (CI = confidence interval; OS = overall survival.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Three-year and 5-year recurrence-free survival for patients with (N+) and without (N−) nodal disease. (CI = confidence interval; RFS = recurrence-free survival.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.